This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.
The total number entries retrieved from this search are 178| Biomarker ID | Biomarker | Biomolecule | Subject | Regulation | Biomarker's type | Experiment | Level of significance | Source | PMID |
|---|---|---|---|---|---|---|---|---|---|
| 2278 | Cyclophilin B (Peptidyl-prolyl cis-trans isomerase B) | Protein | Human | Downregulated in recurrence HCC than non-recurrence HCC (with fold change 0.53) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2279 | ORP150 | Protein | Human | Downregulated in recurrence HCC than non-recurrence HCC (with fold change 0.59) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2280 | Vinculin | Protein | Human | Upregulated in recurrence HCC than non-recurrence HCC (with fold change 1.82) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2281 | Flavin reductase | Protein | Human | Downregulated in recurrence HCC than non-recurrence HCC (with fold change 0.52) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2282 | Stathmin | Protein | Human | Downregulated in recurrence HCC than non-recurrence HCC (with fold change 0.56) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2283 | Protein kinase C inhibitor protein-1 | Protein | Human | Upregulated in recurrence HCC than non-recurrence HCC (with fold change 2.7) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2284 | Heterogeneous nuclear ribonucleoprotein A2/B1 | Protein | Human | Downregulated in recurrence HCC than non-recurrence HCC (with fold change 0.55) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2285 | 26S proteasome non-ATPase regulatory subunit 8 | Protein | Human | Downregulated in recurrence HCC than non-recurrence HCC (with fold change 0.64) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2286 | Glutamine amidotransferase | Protein | Human | Downregulated in recurrence HCC than non-recurrence HCC (with fold change 0.69) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2287 | Phosphoglycerate kinase 1 | Protein | Human | Upregulated in recurrence HCC than non-recurrence HCC (with fold change 1.57) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2288 | TCP-1 chaperonin cofactor A | Protein | Human | Upregulated in recurrence HCC than non-recurrence HCC (with fold change 1.57) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2289 | TCP-1-gamma | Protein | Human | Downregulated in recurrence HCC than non-recurrence HCC (with fold change 0.64) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2290 | Multidrug resistance-associ ated protein MGr1-Ag | Protein | Human | Upregulated in recurrence HCC than non-recurrence HCC (with fold change 1.51) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2291 | Nuclear chloride ion channel 27 | Protein | Human | Upregulated in recurrence HCC than non-recurrence HCC (with fold change 1.64) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2317 | NDRG2 | Protein and RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic and Prognostic | HCC v/s cirrhosis/healthy/non-tumor HCC; associated with recurrence and tumor grade | p < 0.05 | Tissue | 18519680 |
| 2318 | CSTB | Protein and RNAs | Human | Upegulated in HCC than non-tumor | Diagnostic | HCC v/s cirrhosis/healthy/non-tumor HCC | p < 0.05 | Serum | 18281540 |
| 2319 | AFP | Protein | Human | Upegulated in HCC than non-tumor | Diagnostic | HCC v/s cirrhosis/healthy/non-tumor HCC | p < 0.05 | Serum | 18281540 |
| 2320 | CSTB, AFP | Protein | Human | Upegulated in HCC than non-tumor | Diagnostic | HCC v/s cirrhosis/healthy/non-tumor HCC | p < 0.05 | Serum | 18281540 |
| 2324 | ID2 | Protein and RNAs | Human | Downregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.4) | Prognostic | HCC with PVI v/s HCC without PVI | p < 0.005 | Tissue | 17088983 |
| 2359 | RhoC | Protein and RNA | Human | Upregulated in highly invasive NHCC than in less invasive SLHCC and upregulated in EHML (Extrahepatic Metastatic Lesions) than HCC and PCLT (Pericarcinomatous liver tissues). | Prognostic | EHML (Extrahepatic Metastatic Lesions) v/s HCC and PCLT(pericarcinomatous liver tissues); increased RhoC expression strongly correlates with vein invasion | p < 0.01 | Tissue | 15150600 |
| 2419 | IGF2 | Protein | Human | Upregulated in HCC than normal | Diagnostic | HCC v/s normal | (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51) | Tissue | 14517841 |
| 2420 | ADAM9 | Protein | Human | Upregulated in HCC than normal | Diagnostic | HCC v/s normal | (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51) | Tissue | 14517841 |
| 2421 | STAT3 | Protein | Human | Upregulated in HCC than normal | Diagnostic | HCC v/s normal | (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51) | Tissue | 14517841 |
| 2422 | SOCS3 | Protein | Human | Upregulated in HCC than normal | Diagnostic | HCC v/s normal | (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51) | Tissue | 14517841 |
| 2423 | cyclin D1 | Protein | Human | Upregulated in HCC than normal | Diagnostic | HCC v/s normal | (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51) | Tissue | 14517841 |
| 2424 | COL1A1 | Protein | Human | Downregulated in HCC than normal | Diagnostic | HCC v/s normal | (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51) | Tissue | 14517841 |
| 2425 | SMAD4 | Protein | Human | Downregulated in HCC than normal | Diagnostic | HCC v/s normal | (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51) | Tissue | 14517841 |
| 2426 | FHIT | Protein | Human | Downregulated in HCC than normal | Diagnostic | HCC v/s normal | (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51) | Tissue | 14517841 |
| 2427 | SOCS1 | Protein | Human | Downregulated in HCC than normal | Diagnostic | HCC v/s normal | (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51) | Tissue | 14517841 |
| 2428 | IGFBP7 | Protein and RNAs | Human | Downregulated in IFN-resistant cells (with fold change 2.963) | Predictive | IGFBP7-positive HCC patients v/s IGFBP7-negative HCC patients | p < 0.05 | Cell line and Tissue | 20407444 |
| 2467 | GRP94, GRP78, GRP75, HSC71, HSP90, HSP70, HSP60, Aconitase, EF-2, Nucleophosmin, VIM, NDK-A, Argininosuccinate synthase, CPSASE-I, | Protein | Human | Differentially expressed (Argininosuccinate synthase, Carbamoyl-phosphate synthase (CPSASE I) are Downregulated and rest 12 are Upregulated) in HCC tumor v/s non-tumorous | Diagnostic | HCC tumor v/s non-tumorous | p < 0.05 | Tissue | 14654528 |
| 2468 | hnRNP K, HSP70RY, Lamin B1, 40S ribosomal protein SA, FTCD, SOD, Arginase, SMP-30, P5C dehydrogenase, Transitional endoplasmic reticulum ATPase, Ubiquitin carboxyl-terminal hydrolase 5, Thiosulfate sulfurtransferase (Rhodanese), Betaine-himocysteine S-methyltransferase, NCC27, FGB, RACK1, PDI, SARDH | Protein | Human | Differentially expressed (hnRNP K, HSP70 RY, Lamin B1, 40S ribosomal protein SA, Transitional endoplasmic reticulum ATPase, Ubiquitin carboxyl-terminal hydrolase 5, Rhodanese, Betaine-himocysteine S-methyltransferase, NCC27, Fibrinogen β chain, RACK1 are Upregulated and rest 12 are Downregulated) | Diagnostic | HBV associated HCC tumor v/s non-tumorous | p < 0.05 | Tissue | 14654528 |
| 2469 | GABA-AT, Cytosol aminopepsidase, AFB1-AR2, Acyl-CoA dehydrogenase, GDH, | Protein | Human | Differentially expressed (GABA-AT, AFB1-AR2) are Upregulated and rest 3 are Downregulated) in HCC tumor v/s non-tumorous | Diagnostic | HCV associated HCC tumor v/s non-tumorous | p < 0.05 | Tissue | 14654528 |
| 2470 | HSP27, Enoyl-CoA hydratase, Tubulin β chain, Galactose kinase, Ubiquinol-cytochrome C reductase complex core protein I, Annexin V, P-PST, Ribosome binding protein, Fumarylacetoacetase, ALDH, Catalase, | Protein | Human | Differentially expressed (P-PST, Ribosome binding protein, Fumarylacetoacetase, Catalase and ALDH are Downregulated and rest 6 are Upregulated) in HCC tumor v/s non-tumorous | Diagnostic | Both HBV- and HCV associated HCC tumor v/s non-tumorous | p < 0.05 | Tissue | 14654528 |
| 2471 | Protein disulfide isomerase ER-60, PRBP, Tropomyosin 3, ATP synthase, Dihydropipoamide dehydrogenase, FABP, Cathepsin B1, | Protein | Human | Differentially expressed (FABP, Cathepsin B1 are Downregulated and rest 5 are Upregulated) in HCC tumor v/s non-tumorous | Diagnostic | both (HBV and HCV) negative HCC tumor v/s non-tumorous | p < 0.05 | Tissue | 14654528 |
| 2472 | AURKB | Protein and RNAs | Human | Upregulated in HCC tissues in association with aggressive recurrence v/s non-recurrence | Prognostic | Aggressive recurrence HCC v/s non-recurrence HCC | p < 0.001 | Tissue | 18311747 |
| 2473 | hnRNP C1/C2 | Protein | Human | Upregulated in HCC tissues in HCC tumor than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.01 | Tissue | 17627933 |
| 2474 | Hcp70/Hsp90-organizing protein (HOP) | Protein | Human | Upregulated in HCC tissues in HCC tumor than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.01 | Tissue | 17627933 |
| 2475 | GRP-78 | Protein | Human | Upregulated in HCC tissues in HCC tumor than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.01 | Tissue | 17627933 |
| 2476 | heat shock 70-kDa protein 1 | Protein | Human | Upregulated in HCC tissues in HCC tumor than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.01 | Tissue | 17627933 |
| 2477 | heat shock 70-kDa protein 4 | Protein | Human | Upregulated in HCC tissues in HCC tumor than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.01 | Tissue | 17627933 |
| 2478 | T-complex protein 1 | Protein | Human | Upregulated in HCC tissues in HCC tumor than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.01 | Tissue | 17627933 |
| 2479 | MAT | Protein | Human | Downregulated in HCC tissues in HCC tumor than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.01 | Tissue | 17627933 |
| 2480 | GNMT | Protein | Human | Downregulated in HCC tissues in HCC tumor than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.01 | Tissue | 17627933 |
| 2481 | BHMT | Protein | Human | Downregulated in HCC tissues in HCC tumor than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.01 | Tissue | 17627933 |
| 2482 | COMT | Protein | Human | Downregulated in HCC tissues in HCC tumor than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.01 | Tissue | 17627933 |
| 2487 | Protein disulfide isomerase A3 | Protein | Human | Upregulated in HCC than non tumor (with mean ratio of 4.3 +/- 3.7) | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 12481271 |
| 2488 | Heat shock 27 kDa protein | Protein | Human | Downregulated in HCC than non tumor (with mean ratio of nearly 8.4 +/- 5.8) | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 12481271 |
| 2489 | Glycerol-3-phosphate dehydrogenase | Protein | Human | Downregulated in HCC than non tumor (with mean ratio of nearly 9.9 +/- 9.6) | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 12481271 |
| 2490 | Senescence marker protein-30 | Protein | Human | Downregulated in HCC than non tumor (with mean ratio of nearly 7.9 +/- 11.1) | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 12481271 |